Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
Trial record 20 of 92 for:    "social work" | Open Studies

Effects of Behavioral Interventions on Mechanisms of Pain Regulation and Hedonic Regulation

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by University of Utah
Sponsor:
Collaborator:
National Center for Complementary and Integrative Health (NCCIH)
Information provided by (Responsible Party):
Eric Garland, University of Utah
ClinicalTrials.gov Identifier:
NCT02935465
First received: October 11, 2016
Last updated: October 13, 2016
Last verified: October 2016
  Purpose
The overarching aim of this project is to conduct a randomized controlled study to determine whether Mindfulness-Oriented Recovery Enhancement (MORE) vs. a Support Group (SG) can improve pain regulation and hedonic functions (i.e., natural reward responsiveness) thought to be governed by the endogenous opioid system among opioid-treated, chronic, non-neuropathic back pain patients (CNBP) and thereby improve clinical pain, affect, and opioid use.

Condition Intervention
Chronic, Non-neuropathic Back Pain
Behavioral: Mindfulness-Oriented Recovery Enhancement (MORE)
Behavioral: Support Group

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Effects of Behavioral Interventions on Mechanisms of Pain Regulation and Hedonic Regulation in Opioid-Treated Chronic Pain Patients

Resource links provided by NLM:


Further study details as provided by University of Utah:

Primary Outcome Measures:
  • Changes in endogenous opioid system function in response to pain challenge [ Time Frame: Change from week 0 to 8 weeks ]
    PET opioid receptor binding potential from baseline through pain challenge

  • Changes in fMRI activity level during natural reward processing [ Time Frame: Change from week 0 to 8 weeks ]
    Blood oxygen dependent signal (BOLD) response during viewing and regulating response to natural reward cues measured during a fMRI scan.


Secondary Outcome Measures:
  • Pain sensitivity as a measure of volume of hypertonic saline [ Time Frame: Change from week 0 to 8 weeks ]
    Volume of hypertonic saline to maintain pain at 40 out of 100 on a VAS

  • Self-report affect ratings [ Time Frame: Change from week 0 to 8 weeks ]
  • Significant correlation between PET and fMRI measures with improvements in clinical pain, affect, and opioid use [ Time Frame: Change from week 0 to 8 weeks ]

Estimated Enrollment: 140
Study Start Date: September 2016
Estimated Study Completion Date: August 2021
Estimated Primary Completion Date: August 2021 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Mindfulness-Oriented Recovery Enhancement
Participants will attend a Mindfulness-Oriented Recovery Enhancement (MORE) group weekly for eight weeks.
Behavioral: Mindfulness-Oriented Recovery Enhancement (MORE)
Mindfulness-Oriented Recovery Enhancement (MORE) is a group behavioral intervention that unites mindfulness training, cognitive reappraisal, and positive psychological principles into an integrative intervention strategy targeting mechanisms of pain and opioid misuse.
Active Comparator: Support Group
Participants will attend a support group weekly for eight weeks.
Behavioral: Support Group
A conventional support group will allow participants to express emotions, share experiences, and receive social support under the guidance of a skilled therapist.

  Eligibility

Ages Eligible for Study:   21 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. age 21-60 years of age
  2. English fluency
  3. 20/20 vision with corrective lenses
  4. current chronic, non-neuropathic back pain diagnosis determined by physician assessment
  5. reporting pain ≥3 on 0-10 scale with opioid medication
  6. current use of prescription opioids for ≥3 consecutive months
  7. ability to understand study procedures and to comply with them for the entire length of the study

Exclusion Criteria:

  1. Mindfulness experience (e.g., MBSR or shamatha/vipassana meditation)
  2. psychosis
  3. untreated, active suicidality in the past month
  4. and severe non-opioid substance use disorder in the past year as assessed with the MINI
  5. clinically unstable illness judged to interfere with treatment, and presence of facial/jaw pain
  6. pregnancy
  7. inability or unwillingness of individual to give written informed consent
  8. physical characteristics that preclude neuroimaging or study procedures (e.g., metal implants, etc.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02935465

Contacts
Contact: Eric L Garland, PhD eric.garland@socwk.utah.edu
Contact: Sarah Priddy, MSSW utahpainstudy@gmail.com

Locations
United States, Utah
College of Social Work Recruiting
Salt Lake City, Utah, United States, 84112
Contact: Karen Wheeler    801-581-8028    utahpainstudy@gmail.com   
Sponsors and Collaborators
University of Utah
National Center for Complementary and Integrative Health (NCCIH)
Investigators
Principal Investigator: Eric L Garland, PhD The University of Utah
  More Information

Responsible Party: Eric Garland, Associate Director of Integrative Medicine in Supportive Oncology and Survivorship, Huntsman Cancer Institute; Associate Dean for Research and Associate Professor, College of Social Work, University of Utah
ClinicalTrials.gov Identifier: NCT02935465     History of Changes
Other Study ID Numbers: 00093561
Study First Received: October 11, 2016
Last Updated: October 13, 2016
Individual Participant Data  
Plan to Share IPD: Undecided

Additional relevant MeSH terms:
Back Pain
Pain
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms

ClinicalTrials.gov processed this record on May 25, 2017